United States · Funded startup

Who invested in Terns Pharmaceuticals

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$730Mraised across 2 rounds since 2018, from 2 sources

$80MSeries B$650MRound
Latest round
Round, $650MDec 2025
Step-upi
8.1×
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019202020212022202320242025
$80MSeries B$650MRound
First round
Series B, $80M
Oct 2018
Biggest round
$650M
Round · Dec 2025
Between rounds
7.1 years
from the last two

The rounds

  1. Dec 2025
    Round$650M3 new1 returning

    Source recorded

  2. Oct 2018
    Series B$80M3 new

    Reported by Bioworld

Founders and team

From the SEC filings it signed: 4 on the team.

  • Bryan YoonExecutive Officeri
  • Mark VignolaExecutive Officeri
  • Senthil SundaramDirector, Executive Officeri
  • Weidong ZhongExecutive Officer, Directori

On the board, as filediCarl GordonDavid FellowsElise WangHongbo LuJeffrey KindlerJill QuigleyYi Shi

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Vivo CapitalPrivate equity2rounds
OrbiMedPrivate equity1round
Eli LillyCorporate VC1round
Lilly Asia VenturesVC firm1round
Lily AsiaInvestment firm1round
Orbimed/ Dechengno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Terns Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Decheng CapitalVC firmPer its own site

Quick answers about Terns Pharmaceuticals

Who invested in Terns Pharmaceuticals?

Terns Pharmaceuticals's investors include Vivo Capital, OrbiMed, Eli Lilly, Lilly Asia Ventures and Lily Asia, and 1 more on record.

How much has Terns Pharmaceuticals raised?

Terns Pharmaceuticals has raised $730M across 2 rounds since 2018.

When did Terns Pharmaceuticals last raise?

Terns Pharmaceuticals's most recent round was an Undisclosed round of $650M in Dec 2025.

What was Terns Pharmaceuticals's biggest round?

Its most recent round, $650M in Dec 2025, is also its largest on record.

Who backed Terns Pharmaceuticals first?

Terns Pharmaceuticals's first round on record, in Oct 2018, was backed by Vivo Capital, Lily Asia and Orbimed/ Decheng.

What stage is Terns Pharmaceuticals at?

Terns Pharmaceuticals's latest named round is an Undisclosed round, in Dec 2025.

Where is Terns Pharmaceuticals based?

Terns Pharmaceuticals is based in the United States.

Companies like Terns Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.